Aug 26, 2026 | Forensic AI Alerts
As the market for GLP-1 weight loss medications continues to expand, the introduction of oral formulations has created new opportunities for fraud, waste, and abuse (FWA). While oral GLP-1 therapies may improve patient access and convenience, they also introduce...
Aug 17, 2026 | AI in Healthcare
State agencies and Medicaid program integrity leaders have always operated under pressure to safeguard public resources while ensuring members receive the care they need. Today, those expectations are expanding. Recent legislative and regulatory activity across the...
